Mobidiag's diagnostic assays uniquely combine careful assay design, state-of-the-art molecular methods, most reliable detection platforms, and fully automatic result interpretation with the Prove-it^TM Advisor software.

Mobidiag collaborates with clinical laboratories, clinicians and other healthcare professionals in order to develop rapid diagnostics for infectious diseases. We are continuously evaluating new application areas.
Mobidiag's current assays, Prove-it^TM Sepsis and Prove-it^TM Herpes, are based on the PCR amplification of carefully selected gene targets followed by the subsequent detection on an oligonucleotide microarray.
The foundation of the development of new reliable assays is the Prove-it^TM Biobank that is an integrated collection of biological materials, gene sequences, and in silico methods.
The proprietary bioinformatics software Prove-it^TM Advisor automatically reports the pathogen identification. The same modular software can be used with all detection platforms.
Mobidiag uses the most reliable microarray platforms, Prove-it^TM TubeArray and Prove-it^TM StripArray, providing high quality, ease-of-use, and robustness.